As shown in Figure 6A and Supplementary Figure 5, mice that received either EGFR-CAR NK-92, oHSV-1, or their combination had significantly reduced tumor growth compared to those injected with mock-transduced NK-92-EV or vehicle (HBSS). The gene discussed is EGFR; the disease is neoplasm.